Industry Partners

The ubiquitin pathway contains a plethora of novel therapeutic targets. Progenra's ability to discover novel structures with its high throughput assays has created several opportunities for establishing partnerships with other companies.

Progenra is pleased to collaborate with Ono Pharmaceuticals.

Ono logo-24657



Academic Partners

Recognizing that 1) there is still much to discover in the ubiquitin-proteasome pathway and 2) the need for rigorous validation of ubiquitin pathway targets, Progenra encourages academic laboratories to contact us with potential collaborative projects. Progenra is especially interested in prospective collaborations with translational potential.

We are pleased to have collaborations with leading national and international academic institutions including:


Academic Network Logos_Website 2014